Cargando…
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
INTRODUCTION: Two large multicentre European hospital networks have estimated vaccine effectiveness (VE) against COVID-19 since 2021. AIM: We aimed to measure VE against PCR-confirmed SARS-CoV-2 in hospitalised severe acute respiratory illness (SARI) patients ≥ 20 years, combining data from these ne...
Ejemplares similares
-
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
por: Rose, Angela MC, et al.
Publicado: (2023) -
Spotlight influenza: Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, Belgium, 2015 to 2019
por: Subissi, Lorenzo, et al.
Publicado: (2021) -
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study
por: Fischer, Natalie, et al.
Publicado: (2021) -
Influenza versus other respiratory viruses – assessing severity among hospitalised children, Belgium, 2011 to 2020
por: Fischer, Natalie, et al.
Publicado: (2023) -
Identification of SARS-CoV-2 and Enteroviruses in Sewage Water—A Pilot Study
por: Băicuș, Anda, et al.
Publicado: (2021)